Table 4 Breast Cancer Total Cumulative Charges by Initial Treatment at Diagnosis and Charge Type
From: Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer
| Health care charges ($US) | Surgical Resection n=73 | Adjuvant n=553 | Neoadjuvant n=148 | Adjuvant vs. Neoadjuvant | |||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | p-value | |
| Breast Cancer related | |||||||
| Facilities/ Technical |
23,472 (21,512) |
19,840 (28,345) |
27,486 (24,400) |
22,456 (32,113) |
35,877 (27,496) |
33,984 (38,937) | 0.00 |
| Physician/ Professional |
12,942 (10,770) |
10,840 (12,678) |
15,575 (13,091) |
12,449 (17,812) |
17,340 (12,663) |
15,536 (16,820) | 0.04 |
| Pharmacy |
19,702 (57,840) |
993 (2,650) |
37,000 (66,360) |
8,531 (51,815) |
64,705 (79,214) |
43,009 (83,327) | <0.0001 |
| Total Anticancer Treatment |
11,491 (43,165) |
0 (0) |
21,564 (53,960) |
2,241 (13,526) |
40,941 (71,342) |
4,556 (57,935) | 0.00 |
| Clinical Trial |
47 (196) |
0 (0) |
31 (215) |
0 (0) |
78 (297) |
0 (0) | 0.01 |
| Chemotherapy |
3,604 (12,107) |
0 (0) |
7,204 (14,053) |
1,759 (6,352) |
7,376 (10,451) |
3,905 (9,278) | 0.01 |
| Hormonal Therapy |
1,022 (5,843) |
0 (0) |
836 (5,814) |
0 (0) |
399 (2,711) |
0 (0) | 0.95 |
| Biologic Medicine |
6,818 (36,636) |
0 (0) |
13,492 (46,279) |
0 (0) |
33,088 (66,386) |
0 (40,885) | <0.0001 |
| Chemotherapy Administration |
2 (15) |
0 (0) |
0 (4) |
0 (0) |
0 (0) |
0 (0) | . |
| Other Medication(s) |
8,210 (21,536) |
993 (2,559) |
15,436 (23,472) |
2,530 (24,473) |
23,764 (24,934) |
12,018 (42,041) | <0.0001 |